These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

629 related articles for article (PubMed ID: 38352889)

  • 1. Tumour response to hypoxia: understanding the hypoxic tumour microenvironment to improve treatment outcome in solid tumours.
    Bigos KJ; Quiles CG; Lunj S; Smith DJ; Krause M; Troost EG; West CM; Hoskin P; Choudhury A
    Front Oncol; 2024; 14():1331355. PubMed ID: 38352889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-Associated Fibroblasts in the Hypoxic Tumor Microenvironment.
    Kim I; Choi S; Yoo S; Lee M; Kim IS
    Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Tumor Microenvironment in Tumorigenesis and Therapy Resistance Revisited.
    Dzobo K; Senthebane DA; Dandara C
    Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer-associated Fibroblasts in Bladder Cancer: Origin, Biology, and Therapeutic Opportunities.
    Caramelo B; Zagorac S; Corral S; Marqués M; Real FX
    Eur Urol Oncol; 2023 Aug; 6(4):366-375. PubMed ID: 36890105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Jekyll and Hyde: the role of the microenvironment on the progression of cancer.
    Allen M; Louise Jones J
    J Pathol; 2011 Jan; 223(2):162-76. PubMed ID: 21125673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CAF-immune cell crosstalk and its impact in immunotherapy.
    Maia A; Schöllhorn A; Schuhmacher J; Gouttefangeas C
    Semin Immunopathol; 2023 Mar; 45(2):203-214. PubMed ID: 36480035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy.
    Liu Y; Xun Z; Ma K; Liang S; Li X; Zhou S; Sun L; Liu Y; Du Y; Guo X; Cui T; Zhou H; Wang J; Yin D; Song R; Zhang S; Cai W; Meng F; Guo H; Zhang B; Yang D; Bao R; Hu Q; Wang J; Ye Y; Liu L
    J Hepatol; 2023 Apr; 78(4):770-782. PubMed ID: 36708811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxic Effects on Matrix Metalloproteinases' Expression in the Tumor Microenvironment and Therapeutic Perspectives.
    Gonzalez-Avila G; Sommer B; Flores-Soto E; Aquino-Galvez A
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer-Associated Fibroblast Mediated Inhibition of CD8+ Cytotoxic T Cell Accumulation in Tumours: Mechanisms and Therapeutic Opportunities.
    Freeman P; Mielgo A
    Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32967079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment.
    Zhu Y; Li X; Wang L; Hong X; Yang J
    Front Endocrinol (Lausanne); 2022; 13():988295. PubMed ID: 36046791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hypoxic tumour microenvironment.
    Petrova V; Annicchiarico-Petruzzelli M; Melino G; Amelio I
    Oncogenesis; 2018 Jan; 7(1):10. PubMed ID: 29362402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the Evaluation of a Novel Hypoxic 3D Pancreatic Cancer Model as a Tool for Radiotherapy Treatment Screening.
    Wishart G; Gupta P; Nisbet A; Schettino G; Velliou E
    Cancers (Basel); 2021 Dec; 13(23):. PubMed ID: 34885188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CAF-induced physical constraints controlling T cell state and localization in solid tumours.
    Arpinati L; Carradori G; Scherz-Shouval R
    Nat Rev Cancer; 2024 Oct; 24(10):676-693. PubMed ID: 39251836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of hypoxic signalling in metastasis: towards translating knowledge of basic biology into novel anti-tumour strategies.
    Araos J; Sleeman JP; Garvalov BK
    Clin Exp Metastasis; 2018 Oct; 35(7):563-599. PubMed ID: 30171389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular matrix (ECM) stiffness and degradation as cancer drivers.
    Najafi M; Farhood B; Mortezaee K
    J Cell Biochem; 2019 Mar; 120(3):2782-2790. PubMed ID: 30321449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving the synergistic combination of programmed death-1/programmed death ligand-1 blockade and radiotherapy by targeting the hypoxic tumour microenvironment.
    Mudassar F; Shen H; Cook KM; Hau E
    J Med Imaging Radiat Oncol; 2022 Jun; 66(4):560-574. PubMed ID: 35466515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Complexity of the Tumor Microenvironment in Hepatocellular Carcinoma and Emerging Therapeutic Developments.
    Argentiero A; Delvecchio A; Fasano R; Andriano A; Caradonna IC; Memeo R; Desantis V
    J Clin Med; 2023 Dec; 12(23):. PubMed ID: 38068521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance.
    Dzobo K; Dandara C
    OMICS; 2020 Jun; 24(6):314-339. PubMed ID: 32496970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting hypoxia in solid and haematological malignancies.
    Harris B; Saleem S; Cook N; Searle E
    J Exp Clin Cancer Res; 2022 Nov; 41(1):318. PubMed ID: 36320041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of Extracellular Matrix Production in Activated Fibroblasts: Roles of Amino Acid Metabolism in Collagen Synthesis.
    Kay EJ; Koulouras G; Zanivan S
    Front Oncol; 2021; 11():719922. PubMed ID: 34513697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.